Cargando…
Novel vs clinical organ preservation solutions: improved cardiac mitochondrial protection
BACKGROUND: Heart transplantation remains the gold standard for end-stage heart failure, with current ex vivo organ storage times limited to 4 to 6 h before critical tissue damage occurs. Many preservation solutions exist in an attempt to limit both ischemic and reperfusion damage. In order to compa...
Autores principales: | Ferng, Alice S., Schipper, David, Connell, Alana M., Marsh, Katherine M., Knapp, Shannon, Khalpey, Zain |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5270367/ https://www.ncbi.nlm.nih.gov/pubmed/28126002 http://dx.doi.org/10.1186/s13019-017-0564-x |
Ejemplares similares
-
Adipose-derived human stem/stromal cells: comparative organ specific mitochondrial bioenergy profiles
por: Ferng, Alice S., et al.
Publicado: (2016) -
Acellular porcine heart matrices: whole organ decellularization with 3D-bioscaffold & vascular preservation
por: Ferng, Alice S., et al.
Publicado: (2017) -
Anti-inflammatory properties of amniotic membrane patch following pericardiectomy for constrictive pericarditis
por: Marsh, Katherine M., et al.
Publicado: (2017) -
Improved metabolism and redox state with a novel preservation solution: implications for donor lungs after cardiac death (DCD)
por: Schipper, David A., et al.
Publicado: (2017) -
Remodeling an infarcted heart: novel hybrid treatment with transmyocardial revascularization and stem cell therapy
por: Iwanski, Jessika, et al.
Publicado: (2016)